- Forum
- Communities
- Medication Management
- Introducing the Canadian SNOMED CT Drug Extension at the June 2025 HTC Meeting
Introducing the Canadian SNOMED CT Drug Extension at the June 2025 HTC Meeting
- Linda Parisien
-
- Hors Ligne
- Messages : 438
il y a 1 semaine 1 jour #10426
par Linda Parisien
Réponse de Linda Parisien sur le sujet Introducing the Canadian SNOMED CT Drug Extension at the next HTC Meeting
Hi Doug,
Thank you for your message.
The new Canadian SNOMED CT Drug Extension will fulfill many requirements that we will present at the June HTC meeting. We will also talk about the Drug Model and will encourage the community to provide feedback on the content published as part of the Canadian Edition of SNOMED CT. May 30 is the release day of the next Canadian Edition of SNOMED CT.
Thank you for your message.
The new Canadian SNOMED CT Drug Extension will fulfill many requirements that we will present at the June HTC meeting. We will also talk about the Drug Model and will encourage the community to provide feedback on the content published as part of the Canadian Edition of SNOMED CT. May 30 is the release day of the next Canadian Edition of SNOMED CT.
Connexion ou Créer un compte pour participer à la conversation.
- Doug Pankoski
-
- Hors Ligne
- Messages : 1
il y a 2 semaines 5 jours #10397
par Doug Pankoski
Réponse de Doug Pankoski sur le sujet Introducing the Canadian SNOMED CT Drug Extension at the next HTC Meeting
This is great news Helen. I would offer the medication extension remain as "pure" clinical documentation of the medication content identified rather than pursuing a Drug Identification Number (DIN) context used with PrescribeIT to support insurance claims for drug reimbursement. I would also ask input be sought from large Canadian hospital pharmacy departments to capture the many variations of injectable drugs being diluted into various IV fluids and volumes via their parenteral drug admixture programs.
Connexion ou Créer un compte pour participer à la conversation.
- Helen Wu
-
Auteur du sujet
- Hors Ligne
- Messages : 233
il y a 2 semaines 5 jours - il y a 2 semaines 3 jours #10396
par Helen Wu
Introducing the Canadian SNOMED CT Drug Extension at the June 2025 HTC Meeting a été créé par Helen Wu
Hi all,
Several jurisdictions have requested Canada Health Infoway’s (Infoway) support to expand the current medication terminology beyond what is currently available in the Canadian Clinical Drug Data Set (CCDD) using an international terminology such as SNOMED CT. Infoway has approved a project to collaborate with Quebec and other interested Jurisdictions to develop a Canadian SNOMED CT Drug extension. This is a substantial, multi-year initiative with a broad scope and the potential to deliver long-term value to all key partners across Canada.
There is no plan to transition away from using CCDD for PrescribeIT®. We continue to have a requirement for PrescribeIT® stakeholders to support this data set as it provides considerable value to the e-prescribing eco-system, supports pharmacy workflow and patient safety, and enables clinicians to meet regulatory requirements via PrescribeIT® (e.g. for the Alberta Tracked Prescription Program).
A consultation table is being organized to include additional key partners and drug database experts from various jurisdictions. These participants will review and provide feedback on proposals, drafts, and deliverables related to the Canadian SNOMED CT Drug extension. A key success factor of the project is widespread adoption of the terminology across Canada. To facilitate this, it is essential that the terminology is tailored to align with the needs and future integration plans of interested jurisdictions.
The Canadian Medicines Terminology (CMT) Project encompasses the Canadian SNOMED CT drug extension model based on the Canadian-specific requirements, the data transformation process, the mapping rules and principles, the tooling enhancements, the customized modelling templates, and modelling editorial guidelines for representing complex drug products.
The adoption of SNOMED CT standardized codes allows for consistency in data handling and reduces variability in the interpretation of medication data across hospitals, clinics, and pharmacies in Canada. Each phase of the implementation includes SNOMED CT CA codes that align with the international drug data standards, enhancing cross-jurisdictional compatibility. This interoperability is particularly important as provinces like Quebec and other jurisdictions begin integrating SNOMED CT CA for drug data, enabling more reliable medication information sharing across regions.
Would you like to learn more about this project? Join us at the June Health Terminologies Community meeting scheduled for June 17, 2025. Register here for the meeting .
Thank you!
Several jurisdictions have requested Canada Health Infoway’s (Infoway) support to expand the current medication terminology beyond what is currently available in the Canadian Clinical Drug Data Set (CCDD) using an international terminology such as SNOMED CT. Infoway has approved a project to collaborate with Quebec and other interested Jurisdictions to develop a Canadian SNOMED CT Drug extension. This is a substantial, multi-year initiative with a broad scope and the potential to deliver long-term value to all key partners across Canada.
There is no plan to transition away from using CCDD for PrescribeIT®. We continue to have a requirement for PrescribeIT® stakeholders to support this data set as it provides considerable value to the e-prescribing eco-system, supports pharmacy workflow and patient safety, and enables clinicians to meet regulatory requirements via PrescribeIT® (e.g. for the Alberta Tracked Prescription Program).
A consultation table is being organized to include additional key partners and drug database experts from various jurisdictions. These participants will review and provide feedback on proposals, drafts, and deliverables related to the Canadian SNOMED CT Drug extension. A key success factor of the project is widespread adoption of the terminology across Canada. To facilitate this, it is essential that the terminology is tailored to align with the needs and future integration plans of interested jurisdictions.
The Canadian Medicines Terminology (CMT) Project encompasses the Canadian SNOMED CT drug extension model based on the Canadian-specific requirements, the data transformation process, the mapping rules and principles, the tooling enhancements, the customized modelling templates, and modelling editorial guidelines for representing complex drug products.
The adoption of SNOMED CT standardized codes allows for consistency in data handling and reduces variability in the interpretation of medication data across hospitals, clinics, and pharmacies in Canada. Each phase of the implementation includes SNOMED CT CA codes that align with the international drug data standards, enhancing cross-jurisdictional compatibility. This interoperability is particularly important as provinces like Quebec and other jurisdictions begin integrating SNOMED CT CA for drug data, enabling more reliable medication information sharing across regions.
Would you like to learn more about this project? Join us at the June Health Terminologies Community meeting scheduled for June 17, 2025. Register here for the meeting .
Thank you!
Dernière édition: il y a 2 semaines 3 jours par Helen Wu.
Connexion ou Créer un compte pour participer à la conversation.
Modérateurs: Linda Monico, Seema Nayani